Results 131 to 140 of about 120,918,193 (215)

Molecular epidemiological characterization of influenza A（H3N2） virus in Fengxian District， Shanghai， in the surveillance year of 2023

Shanghai yufang yixue
ObjectiveTo understand the epidemiological distribution and gene evolutionary variation of influenza A (H3N2) viruses in Fengxian District, Shanghai, in the surveillance year of 2023, and to provide a reference basis for influenza prevention and control ...
ZHAO Hongwei, TAO Lixin, XIE Xiaohong, HU Yi, ZHAO Xue, LIU Meihua, ZHANG Qingyuan, LU Lijie, LIU Chen’an, WU Mei   +9 more
doaj   +1 more source

Fall Influenza A(H3N2) Outbreak at a Midwestern University [PDF]

JAMA, 2022
openaire   +2 more sources

Predictability of antigenic evolution for H3N2 human influenza A virus

Genes & Genetic Systems, 2013
Influenza A virus continues to pose a threat to public health. Since this virus can evolve escape mutants rapidly, it is desirable to predict the antigenic evolution for developing effective vaccines. Although empirical methods have been proposed and reported to predict the antigenic evolution more or less accurately, they did not provide much insight ...
openaire   +3 more sources

Efficacy and Cross-protection of a Bivalent HINl/H3N2 Swine Influenza Vaccine in Swine Challenged with Swine Influenza Virus Subtype H3N2

, 2000
Rapp-Gabrielson, Vicki; Gergen, Linda; Eddy, Bradley; Wasmoen, Terri; Lechtenberg, Kelly; Hanna, Michael. (2000). Efficacy and Cross-protection of a Bivalent HINl/H3N2 Swine Influenza Vaccine in Swine Challenged with Swine Influenza Virus Subtype H3N2 ...
Rapp-Gabrielson, Vicki, Gergen, Linda, Eddy, Bradley, Hanna, Michael, Wasmoen, Terri, Lechtenberg, Kelly   +5 more
core  

VirPLM: antigenic prediction of influenza A/H3N2 viruses with a fine-tuned protein language model. [PDF]

Bioinformatics
Li X, Xiao K, Zhou C, Jia X, Zhao D, Xu J, Zeng X, Shi J, Shang X, Zhu J, Kong H.   +10 more
europepmc   +1 more source

Alignment-free prediction of cross-reactivity in influenza A (H3N2) anticipates antigenic drift. [PDF]

PLoS Comput Biol
Forna A, Damodaran L, Gunning CE, Rahimi P, Venkat A, Kannan N, Kondor R, Bahl J, Rohani P, Drake JM.   +9 more
europepmc   +1 more source

A Cluster of Influenza A(H3N2) Viruses in 2024 From Tasmania, Australia, With Reduced Susceptibility to Baloxavir. [PDF]

Influenza Other Respir Viruses
Hussain S, Chia C, Muraleetharan A, Deng YM, Dong X, Chanthalavanh P, Takashita E, Dapat C, Miller JE, Peck H, Lee RTC, Williamson J, Cooley L, Maurer-Stroh S, Barr IG.   +14 more
europepmc   +1 more source

Early-Season Detection of Influenza A(H3N2) Subclade K in Wastewater, Colorado, USA, 2025-2026. [PDF]

Emerg Infect Dis
Hetherington-Rauth MC, Nguyen V, Washeleski E, Vital KC, Lequia G, Aragon D, Alden NB, Weisbeck K, Bankers L, Rossheim A, Wheeler A, Matzinger SR.   +11 more
europepmc   +1 more source

Molecular Characterization of Influenza A(H3N2) Hemagglutinin Variants Circulating in Western Mexico, 2022. [PDF]

Int J Mol Sci
Hernandez-Gonzalez KM, Carranza-Aranda AS, Muñoz-Valle JF, Muñoz-Miranda LA, Vega-Magaña AN, Pereira-Suárez AL, Nava-Valdivia CA.   +6 more
europepmc   +1 more source

Epitope-guided optimization improves the protective efficacy of NA-based mRNA vaccines against seasonal influenza A(H3N2) virus. [PDF]

J Microbiol
Kim H, Lee S, Cho S, Shin W, Lee S, Demirev AV, Lee T, Kim YJ, Kim D, Song SA, Jun KR, Kim JI.   +11 more
europepmc   +1 more source